Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFUL.L Regulatory News (FUL)

  • There is currently no data for FUL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EPT Disclosure

25 Mar 2010 09:35

RNS Number : 1684J
Seymour Pierce Ltd
25 March 2010
 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS

WITH RECOGNISED INTERMEDIARY STATUS

DEALING IN A CLIENT-SERVING CAPACITY

(Rule 38.5(a) of the Takeover Code)

 

1. KEY INFORMATION

 

Name of exempt principal trader

Seymour Pierce Limited

Company dealt in

Fulcrum Pharma plc

Class of relevant security to which the dealings being disclosed relate (Note 1)

Ordinary 1p Shares

Date of dealing

24.03.10

 

 

2. DEALINGS (Note 2)

 

(a) Purchases and sales

 

Total number of securities purchased

 

Highest price paid (Note 3)

Lowest price paid (Note 3)

5,000

0.02560 GBP

0.02560 GBP

 

 

Total number of securities sold

 

Highest price received (Note 3)

Lowest price received (Note 3)

 

(b) Derivatives transactions (other than options)

 

Product name,

e.g. CFD

Long/short (Note 4)

Number of securities (Note 5)

Price per unit (Note 3)

 

 

 

 

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

 

Product name,

e.g. call option

 

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 5)

Exercise

price

Type, e.g. American, European etc.

Expiry

date

Option money

paid/received per unit (Note 3)

 

(ii) Exercising

 

Product name, e.g. call option

Number of securities

Exercise price per unit (Note 3)

 

 

 

 

 

3. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

Date of disclosure

25.03.10

Contact name

Caroline Woodyer

Telephone number

020 7107 8056

Name of offeree/offeror with which connected

Fulcrum Pharma plc

Nature of connection (Note 6)

Nomad and Broker

 

 

Notes

 

The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
EMMKKPDNCBKKPNB
Date   Source Headline
5th Jul 20177:00 amRNSNotice of Results
28th Apr 20177:00 amRNSPDMR Shareholding
3rd Apr 20177:00 amRNSYear end trading update
22nd Mar 20177:00 amRNSHolding(s) in Company
17th Mar 20179:26 amRNSGrant of options
11th Jan 20173:45 pmRNSDirector/PDMR Shareholding
16th Dec 20167:00 amRNSHalf-year Report
31st Oct 20164:31 pmRNSTotal Voting Rights
14th Oct 20166:10 pmRNSDirector/PDMR Shareholding
26th Sep 20169:52 amRNSDirectorate Change
8th Sep 20164:43 pmRNSPDMR Shareholding
31st Aug 20167:00 amRNSTotal Voting Rights
25th Aug 201610:52 amRNSResult of AGM
25th Aug 20167:00 amRNSAGM Statement
5th Aug 20162:10 pmRNSExercise of warrants
3rd Aug 20163:02 pmRNSPosting of Annual Report and Notice of AGM
28th Jul 20161:22 pmRNSGrant of options
14th Jul 20167:00 amRNSFinal Results
22nd Jun 20165:52 pmRNSDirector Shareholding
27th Apr 20164:54 pmRNSDirector Shareholding
11th Apr 201610:00 amRNSChange of Registered Office
4th Apr 20167:00 amRNSYear end trading update
16th Mar 20164:05 pmRNSDirector Shareholding
3rd Mar 201612:42 pmRNSDirector Shareholding
17th Dec 20157:00 amRNSHalf Yearly Report
3rd Nov 20151:25 pmRNSDirector Shareholding
2nd Nov 20157:00 amRNSNew franchise agreement and restaurant update
28th Aug 201511:00 amRNSResult of AGM
31st Jul 20157:00 amRNSFinal Results
29th Jul 20157:01 amRNSNotice of Results
15th May 201512:25 pmRNSDirector/PDMR Shareholding
30th Apr 20155:30 pmRNSTotal Voting Rights
23rd Apr 20154:20 pmRNSTotal Voting Rights
20th Apr 201511:05 amRNSResult of general meeting and restaurant update
30th Mar 20157:01 amRNSProposed acquisition, fundraising, notice of GM
30th Mar 20157:00 amRNSNew banking arrangements
19th Dec 20147:00 amRNSHalf Yearly Report
18th Nov 20144:30 pmRNSHolding(s) in Company
18th Nov 20144:30 pmRNSHolding(s) in Company
20th Oct 20148:00 amRNSFirst day of dealings on AIM
9th Jun 20104:06 pmRNSOffer Declared Wholly Unconditional
3rd Jun 20107:00 amRNSOffer Extended
25th May 201011:20 amRNSForm 8.5 (EPT/RI)
21st May 201012:06 pmRNSForm 8.3 - Fulcrum Pharma PLC
20th May 20107:00 amRNSOffer Extended
11th May 20109:13 amRNSForm 8.5 (EPT/RI)
10th May 20108:23 amRNSForm 8.5 (EPT/RI)
6th May 201011:27 amRNSForm 8.5 (EPT/RI) Fumcrum Pharma
5th May 20108:49 amRNSForm 8.5 (EPT/RI)
4th May 201011:46 amRNSForm 8.5 (EPT/RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.